美国能源部和 PBBM驱动的配方开发一种延长释放的多尼佩齐尔片
Frederico Severino Martins1, Leonardo Luiz Borges2,3, Sivacharan Kollipara4
1Institute of Technology and Research (ITP), Av. Murilo Dantas, 300, Aracaju 49010-390, Sergipe, Brazil.
Pharmaceuticals (Basel, Switzerland)
|December 31, 2025
概括
整合实验设计 (DoE) 与生理基础生物制药建模 (PBBM) 简化了延长释放 (XR) 配方开发. 这种方法加快了生物同等药物产品的上市时间.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 计算制药学 计算机制药学
背景情况:
- 延长释放 (XR) 配方的开发是复杂的,资源密集的.
- 优化配方变量以实现所需的药物释放概况是具有挑战性的.
- 目前的方法通常需要进行广泛的体内研究,增加开发时间和成本.
研究的目的:
- 整合实验设计 (DOE) 与生理基础生物制药建模 (PBBM) 进行高效的XR配方开发.
- 使用系统的实验设计优化延长释放的多内 (DPZ) 配方.
- 评估虚拟生物等价性 (VBE) 研究的潜力.
主要方法:
- 采用Box-Behnken实验设计来评估HPMC 100,HPMC 4000和NaCMC对药物释放,水化和侵蚀的影响.
- 试管溶解数据被整合到一个PBBM框架中.
- 基于生理学的生物制药建模 (PBBM) 用于模拟药物释放和药理动力学.
主要成果:
- 为多尼 (DPZ) 开发了一种优化的XR配方,其溶解状况与参考产品相似.
- 综合的DoE和PBBM方法为配方性能提供了强大的预测洞察力.
- 启用了虚拟生物等价性 (VBE) 评估,减少了对体内研究的依赖.
结论:
- 联合的DoE和PBBM方法提供了一个可扩展和可泛化的策略,用于高效的XR配方开发.
- 利用先进的统计方法和in silico建模可以加速开发具有成本效益的生物等价药物.
- 这种综合方法大大缩短了制药创新的上市时间.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
376
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
376
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
275
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
275
Biopharmaceutical Factors Influencing Drug Product Design: Overview
217
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
217
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
180
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
180
Drug Dissolution: Requirements and Profile Comparison
208
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
208
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
477
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
477


